Introduction
economic cost of treating tobacco related diseases was 6.7 billion USD in 2011, nearly 25% of which was attributed to smokeless tobacco use. 5 Although SLT use has serious health and economic implications, this burden has not been given due importance internationally. Recently, Global Burden of Diseases, Injuries, and Risk Factors Study (GBD 2016) has included the burden attributable to smokeless tobacco. In their study it was found that RR (Relative Risk) of SLT was higher than one for oral cancer and esophageal cancer except for snuff or snus. 6 The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) 2014 implementation global progress report provide only limited information on SLT use prevalence and control efforts. 7 One hundred and eighty countries that have ratified the WHO FCTC are obliged to monitor information on tobacco use, including SLT use among both adults and youth and related indicators using standard protocols for national and international comparability; 7 however, specific actions have been limited to date. 8 Addressing smokeless tobacco use has begun to gain attention through the FCTC process. WHO FCTC global knowledge hub on smokeless tobacco has been established in India with a mandate to create scientific evidence on different aspects of SLT control and help member states in improving SLT control.
In 2014, based on smokeless tobacco use prevalence from 70 countries, the number of SLT users was estimated to be 302.4 million worldwide. 9 In 2015, based on information from 121 countries, 10 the global estimate of SLT users was calculated to be 351.9 million. Information on the prevalence of smokeless tobacco use among adults along with associated demographic factors is available in several independent studies for individual countries or groups of countries. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] However, the demographic factors associated with SLT use, such as gender, place of residence, and economic status of the countries and families, have not yet been explored at a global level. This knowledge would help in understanding the patterns of SLT use and suggesting points of intervention to address the problem of SLT use worldwide. This study computed the global burden of SLT use among adults based on prevalence from 140 countries and studied the relationship of the gender, the income of the country and family, and the place of residence to prevalence.
Methods
The information was obtained from various sources including published WHO reports, 11 other multi-country international reports, [1] [2] [3] [9] [10] [11] [12] [13] [14] [15] [16] as well as individual country reports 17, 18 (Supplementary Table 1 ). The data for prevalence of current SLT use (defined as use within past 30 days) for adults was obtained for 145 countries. Adults were age 15 years and plus. The most recent national estimates obtained from population based surveys of current SLT use were included in calculations. The four countries having sub national estimates (adults) and one country having other definitions of current SLT use (e.g. SLT use in past 12 months) were excluded from the calculations. The countries were categorized by income group following the World Bank classification, 19 which provides four major income groups, namely, LICs (Low income countries), LMICs (Lower middle income countries), UMICs (Upper middle income countries), and HICs (High income countries). Two income groups were constituted for the analysis: Group 1, which includes LIC + LMIC, and Group 2 with HIC + UMIC.
The prevalence of SLT use was computed by gender for all countries and, additionally, by place of residence and family income for Group 1 countries in South-East Asia Region (SEAR) and African Region (AFR). Mean prevalence of SLT use for countries were computed using the standard weighting calculation as given below:
where x = weighted mean, w = population of individual countries, x = prevalence of individual countries. Based on asymmetry of the distribution, Mann-Whitney U test was employed for calculating the significance for difference. The number of male and female SLT users of the corresponding age groups in the respective countries was computed using the standard method. 9, 10 The population figures were taken from UN population reports for 2015. 20 Numbers of users were calculated for different categories and sub regions, such as by country income group and by WHO region. SPSS version 16 was used for statistical computations.
In low-middle income and low income countries of SEAR and AFR, difference in smokeless tobacco use prevalence by place of residence (urban vs. rural population) was compared. Further, prevalence in such countries were seen between richest and poorest. All countries included in this study had five socioeconomic (SES) categories. Categories one with highest family income and category five with lowest family income groups were compared.
Results

Prevalence and Demographic Associations of SLT Use
For 140 countries, the mean prevalence of SLT use was 10.4% among males and 5.6%among females. The male-female differential persisted across all classifications. Table 1 shows the mean prevalence of smokeless tobacco use by gender, place of residence (urban vs. rural) and family income across different country income groups. The mean prevalence of SLT use was significantly higher among both males and females of Group 1 countries (18.4% male, 10.4% female) compared with their counterparts in Group 2 countries (1.9% male, 0.5% female; p < .001). Indeed, the mean prevalence was 20 fold higher in females and 10 fold higher in males of Group 1 countries compared to Group 2 countries.
Distribution of Adult SLT Users
In 140 countries, there were estimated 356 million SLT users, out of which 65.8% (234 million) were males while 34.2% (122 million) were females (Supplementary 1). Figure 2 ).
Of all SLT users, overall 90.7% resided in Group 1 countries, 9.3% in Group 2 countries (Figure 1) .A higher proportion of female (94.3%) than male (88.8%) users resided in LIC and LMICs.
Of all SLT users 81.6% lived in South-East Asia region (SEAR) followed by the African region (AFR); 4.8%), American region (AMR; 4.3%), Eastern Mediterranean region (EMR; 3.8%), European region (EUR; 3.3%), and Western Pacific region (WPR; 2.2%), Supplementary Figure 1 .
SLT Use by Place of Residence and Income of the Family in LIC and LMICs
SLT use is 1.2-8 times higher in rural areas as compared to urban in countries of SEAR and AFR (Supplementary 1 Table 2 ; Supplementary 1 Figure 3 ). SLT use was 1.5-17 times higher among poorest section as compared to the richest section in countries of SEAR and AFR (Supplementary 1 Table 3 ; Supplementary Figure 4) .
Discussion
Smokeless tobacco use is a global epidemic affecting 140 countries representing 93.8% of the global population. This study provides a more representative global estimate as compared to the earlier studies that were based on findings from 70 and 121 countries respectively. 9, 10 The WHO had estimated global SLT use prevalence for male as 12% and for female 7% in 2014. 8 The present study estimates 10.4% SLT use among males and 5.6% among females. This study also provides a more accurate and updated estimate of users by region. Nearly 82% of global SLT users lived in SEAR, which is one percent less than a previous estimate. 10 This one percent is made up in the African region, where the global estimate changed from 4% to 5%.
Lack of availability of data on SLT use among adults was a major challenge in the past which has been compensated by secondary analyzed data published in recent years. [12] [13] [14] [15] [16] The available data on SLT use, however, lacks uniformity in various aspects. This creates difficulty in accurate comparison of prevalence across different countries and also across different time periods as different survey instruments, sampling methods and age groups have been used at different times. Now countries may use the Standard Tobacco Questions for Surveys (TQS) developed by WHO and CDC in ongoing surveys so that uniformity in the available SLT data may be maintained.
Our analysis reveals that the mean prevalence of current use of SLT was significantly higher among males in both group 1 (p < .01) and group 2 countries (p < .01) compared to females. However, the prevalence among females is higher than males in some high burden countries, such as Bangladesh (27.9% vs. 26.9%) and Timor-Leste (26.8% vs. 16.1%). It was observed that nearly 95% of global female users lived in LIC and LMICs, (Figure 1 ) perhaps because the use of SLT by women is more socially acceptable in LIC and LMICs. Apart from cultural acceptance, easy accessibility and affordability of smokeless tobacco and tobacco industry interference are additional reason for its higher use among people in LIC and LMICs.
This study provides further support that most of the high smokeless tobacco use burden countries are LICs and LMICs. India, Bangladesh, Myanmar, Indonesia, Pakistan, Nepal, and Madagascar are among the top 10 countries with high SLT use prevalence and contribute high numbers of SLT users to the overall global estimate. Although SLT use prevalence was comparatively low in the USA, China, and Indonesia, they also come into the list of 10 top high burden countries because of their large population size.
Overall almost 91% of SLT users reside in LICs and LMICs, and the greatest burden in these countries is among the poorest families. But, though smokeless tobacco use is major problem in LIC and LMICs, limited progress has been made in implementing effective tobacco control strategies targeted at SLT in these countries. Taxes on smokeless tobacco products tend to be lower than those on cigarettes and the affordability of SLT products has increased over the years due to inadequate taxation. 21 Evidence demonstrates that increased taxes on raw tobacco and on SLT products are one of the most effective tools 9 to reduce SLT use and its affordability. In order to achieve the UN target of a 30% reduction in tobacco use by 2025, greater attention is needed, especially in LICs and LMICs and in the SEAR region, to the burden of SLT use, along with the implementation of evidence based strategies for its control.
Limitations
Adult prevalence is based on surveys, reported by self or family members; not authenticated by biomarkers. WHO region-wise sample coverage for adults was more than 85% for all regions with the exception of the Eastern Mediterranean Region (EMR; 66.6%). Age group coverage for the survey results were not the same for all countries. The majority of the studies were for 15+ whereas the second largest group was 25+. All prevalence data reported is not for the same calendar year. 
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